Mini-Mental State (MMS-LS) and Sign Language

NCT ID: NCT02005679

Last Updated: 2019-02-15

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

195 participants

Study Classification

INTERVENTIONAL

Study Start Date

2011-06-17

Study Completion Date

2017-12-07

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In France the prevalence of pre-lingual deafness is between 1 and 1.4 per 1000 habitants, and according to very conservative estimates, about 44 000 deaf persons use the sign language. Additionally, the prevalence of dementia in France is close to 1% (850 000 dements for a total population of 65 millions). The prevalence of dementia in pre-lingual deaf adults has also been described and is between 1 and 1.4 /100 000 habitants.

The Mini Mental State Examination (MMSE) of Folstein is a test recommended to perform the cognitive evaluation for the detection of mental disorders including dementia, and a consensual French version exists prepared by GRECO (Group of Research and Cognitive Assessments). However, to date, there are no simple, rapid and validated screening tests to study cognitive disorders in deaf persons who use the sign language. The only tests available allow a late diagnosis avoiding an optimal treatment of the patients.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The objective of this study is to assess the intrinsic quality of the tool MMS-LS, a mini-mental state examination that has been adapted to the sign language in order to monitor cognitive disorders in deaf people who speak sign language.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Prelingual Deafness Retention Disorders, Cognitive

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

deaf persons with potential dementia

Group Type EXPERIMENTAL

application of the mini-mental state test

Intervention Type BEHAVIORAL

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

application of the mini-mental state test

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adults\> 18 years
* Pre-lingual deafness
* Use of French sign language

Exclusion Criteria

* Refusal to sign the consent
* Severe visual impairment with lower acuity (less than 0.5)
* Severe motor difficulties impeding the practice of sign language
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Lille Catholic University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Benoît Drion, MD

Role: STUDY_DIRECTOR

Groupement des Hôpitaux de l'Institut Catholique de Lille, Unité d'Accueil et de Soins des Sourds en Langue des Signes et Réseau Sourds et Santé

Amélie Lansiaux, MD

Role: STUDY_CHAIR

Groupement des Hôpitaux de l'Institut Catholique de Lille, Medical Research Department

Isabelle Ridoux, MD

Role: PRINCIPAL_INVESTIGATOR

CHU de Rennes, Hôpital de Pontchaillou

Corine Gilda Scemama-Ammar, MD

Role: PRINCIPAL_INVESTIGATOR

Hôpital de la Conception, Pôle psychiatrie, Marseille

Charlotte Crinquette, MD

Role: PRINCIPAL_INVESTIGATOR

Groupement des Hôpitaux de l'Institut Catholique de Lille

Isabelle Bouillevaux, MD

Role: PRINCIPAL_INVESTIGATOR

CHRU de Nancy, Unité Régionale d'Accueil et de Soins pour Sourds et malentendants

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hôpital de la Conception, Pôle psychiatrie Centre

Marseille, Bouches-du-Rhône, France

Site Status

Groupement des Hôpitaux de l'Institut Catholique de Lille

Lille, Hauts-de-France, France

Site Status

CHU de Rennes, Hôpital de Pontchaillou

Rennes, Ille-et-Vilaine, France

Site Status

Unité Régionale d'Accueil et de Soins pour Sourds et malentendants - CHRU Nancy

Nancy, Meurthe-et-Moselle, France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

RC-P0008

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.